WallStreetZenWallStreetZen

NASDAQ: SPRO
Spero Therapeutics Inc Stock Ownership - Who owns Spero Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Spero Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy KeutzerChief Operating Officer2025-08-281,695$1.97
$3.34kSell
Ankit MahadeviaDirector2025-08-286,572$1.97
$12.95kSell
Timothy KeutzerChief Operating Officer2025-02-0524,920$0.78
$19.44kSell
Ankit MahadeviaDirector2025-02-0513,959$0.78
$10.89kSell
Ankit MahadeviaDirector2025-02-0555,260$0.78
$43.10kSell
Sath ShuklaCEO President2025-02-05106,408$0.78
$83.00kSell
Timothy KeutzerChief Operating Officer2025-02-0527,643$0.78
$21.56kSell
Sath ShuklaCEO President2025-02-0542,786$0.78
$33.37kSell
Timothy KeutzerChief Operating Officer2025-02-053,974$0.78
$3.10kSell
Esther RajaveluCFO CBO2025-02-0520,689$0.78
$16.14kSell

1 of 2

SPRO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SPRO insiders and whales buy or sell their stock.

SPRO Shareholders

What type of owners hold Spero Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aquilo Capital Management LLC20.62%11,606,674$27.04MInsider
Gsk PLC16.33%9,190,606$21.41MInsider
Glaxosmithkline PLC6.73%3,788,012$8.83MInsider
Jean Francois Formela4.28%2,408,128$5.61MInsider
Pfizer Inc4.20%2,362,348$5.50MInstitution
Vanguard Group Inc3.47%1,950,381$4.54MInstitution
Vikas Goyal3.29%1,854,006$4.32MInsider
Sath Shukla3.09%1,736,883$4.05MInsider
Anson Funds Management LP2.87%1,615,469$3.76MInstitution
Casper Breum1.94%1,091,774$2.54MInsider

1 of 3

SPRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SPRO19.69%64.04%Net SellingNet Selling
ANIX16.25%82.80%Net Buying
ABOS62.08%17.23%Net Selling
CLYM73.63%9.49%Net Selling
ACTU26.83%73.17%Net Buying
View Top Biotech Stocks

Spero Therapeutics Stock Ownership FAQ

Who owns Spero Therapeutics?

Spero Therapeutics (NASDAQ: SPRO) is owned by 19.69% institutional shareholders, 64.04% Spero Therapeutics insiders, and 16.27% retail investors. Aquilo Capital Management LLC is the largest individual Spero Therapeutics shareholder, owning 11.61M shares representing 20.62% of the company. Aquilo Capital Management LLC's Spero Therapeutics shares are currently valued at $27.39M.

If you're new to stock investing, here's how to buy Spero Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.